Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine

Paul E. Makidon, Anna U. Bielinska, Shraddha S. Nigavekar et al. · 2008

Read Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine by Paul E. Makidon, Anna U. Bielinska, Shraddha S. Nigavekar et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002954.txt.

Description

Paul Makidon, Anna Bielinska, Shraddha Nigavekar and co-authors tested a new hepatitis B vaccine form in animals in 2008. Hepatitis B stays a major global health problem despite safe, effective vaccines. Current vaccines need cold storage and three shots, which restricts use where clinics are scarce.

Their candidate uses a nanoemulsion, a mix of tiny oil droplets, given through the nose as a mucosal vaccine. Pre-clinical evaluation means testing before human trials. Published in PLOS ONE, the work explores a form that could ease delivery in the developing world if later trials support it.

Catalog record

CREATORPaul E. Makidon, Anna U. Bielinska, Shraddha S. Nigavekar et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE72 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002954

Browse the full library · About the Tower of Babel